Figure 3.
Effects of empagliflozin versus placebo on heart failure outcomes and mortality. BMI, body mass index; CI, confidence interval; CV, cardiovascular; HHF, hospitalization for heart failure; HR, hazard ratio; py, patient‐years.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.